Alejandra Guerchicoff1, Sorin J Brener2, Akiko Maehara1, Bernhard Witzenbichler3, Martin Fahy1, Ke Xu1, Bernard J Gersh4, Roxana Mehran5, C Michael Gibson6, Gregg W Stone7. 1. Cardiovascular Research Foundation, New York, New York. 2. Cardiovascular Research Foundation, New York, New York; New York Methodist Hospital, Brooklyn, New York. Electronic address: sjb9005@nyp.org. 3. Charité Campus Benjamin Franklin, Berlin, Germany. 4. Mayo Clinic, Rochester, Minnesota. 5. Cardiovascular Research Foundation, New York, New York; Mount Sinai Hospital, New York, New York. 6. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. 7. Cardiovascular Research Foundation, New York, New York; Columbia University Medical Center, New York, New York.
Abstract
OBJECTIVES: Our aim was to study the impact of delay from symptom onset to first coronary device on infarct size and clinical outcomes at 30 days and 1 year in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention. BACKGROUND: Longer delay from symptom onset to reperfusion has been linked to increased mortality and worse clinical outcome. The mechanisms underpinning this association are not entirely clear. METHODS: The INFUSE-AMI trial (INFUSE-Anterior Myocardial Infarction) randomized patients with anterior STEMI undergoing primary percutaneous coronary intervention with bivalirudin anticoagulation within 5 h of symptom onset to intralesion (IL) bolusabciximab versus no abciximab and to thrombus aspiration versus no aspiration. The primary endpoint was contrast magnetic resonance infarct size (IS) (percentage of left ventricular mass) at 30 days. Time to reperfusion was classified as <3 versus ≥3 h. RESULTS: There were 280 patients (62%) with <3-h delay and 170 patients (38%) with ≥3-h delay. Patients with longer delay were significantly older, more often women, and diabetic. Earlier reperfusion was not associated with higher rates of final Thrombolysis In Myocardial Infarction flow grade 3 or myocardial blush grade 2/3, but was an independent predictor of smaller IS (p = 0.02 by multivariable linear regression). Mortality at 1 year was reduced in patients with shorter delay to reperfusion (4.0% vs. 9.2%, p = 0.02). CONCLUSIONS: In patients with large anterior myocardial infarction undergoing relatively early reperfusion, longer delays to reperfusion were associated with larger IS and 1-year mortality, but not with reduced reperfusion success. (The INFUSE - Anterior Myocardial Infarction [AMI] Study; NCT00976521).
RCT Entities:
OBJECTIVES: Our aim was to study the impact of delay from symptom onset to first coronary device on infarct size and clinical outcomes at 30 days and 1 year in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention. BACKGROUND: Longer delay from symptom onset to reperfusion has been linked to increased mortality and worse clinical outcome. The mechanisms underpinning this association are not entirely clear. METHODS: The INFUSE-AMI trial (INFUSE-Anterior Myocardial Infarction) randomized patients with anterior STEMI undergoing primary percutaneous coronary intervention with bivalirudin anticoagulation within 5 h of symptom onset to intralesion (IL) bolus abciximab versus no abciximab and to thrombus aspiration versus no aspiration. The primary endpoint was contrast magnetic resonance infarct size (IS) (percentage of left ventricular mass) at 30 days. Time to reperfusion was classified as <3 versus ≥3 h. RESULTS: There were 280 patients (62%) with <3-h delay and 170 patients (38%) with ≥3-h delay. Patients with longer delay were significantly older, more often women, and diabetic. Earlier reperfusion was not associated with higher rates of final Thrombolysis In Myocardial Infarction flow grade 3 or myocardial blush grade 2/3, but was an independent predictor of smaller IS (p = 0.02 by multivariable linear regression). Mortality at 1 year was reduced in patients with shorter delay to reperfusion (4.0% vs. 9.2%, p = 0.02). CONCLUSIONS: In patients with large anterior myocardial infarction undergoing relatively early reperfusion, longer delays to reperfusion were associated with larger IS and 1-year mortality, but not with reduced reperfusion success. (The INFUSE - Anterior Myocardial Infarction [AMI] Study; NCT00976521).
Authors: Gregory M Ouellet; Mary Geda; Terrence E Murphy; Sui Tsang; Mary E Tinetti; Sarwat I Chaudhry Journal: J Am Geriatr Soc Date: 2017-10-18 Impact factor: 5.562
Authors: Chris F Bladin; Kathleen L Bagot; Michelle Vu; Joosup Kim; Stephen Bernard; Karen Smith; Grant Hocking; Tessa Coupland; Debra Pearce; Diane Badcock; Marc Budge; Voltaire Nadurata; Wayne Pearce; Howard Hall; Ben Kelly; Angie Spencer; Pauline Chapman; Ernesto Oqueli; Ramesh Sahathevan; Thomas Kraemer; Casey Hair; Dion Stub; Dominique A Cadilhac Journal: BMJ Open Date: 2022-07-18 Impact factor: 3.006
Authors: Chahua Huang; Yang Liu; Andrew Beenken; Lin Jiang; Xiang Gao; Zhifeng Huang; Anna Hsu; Garrett J Gross; Yi-Gang Wang; Moosa Mohammadi; Jo El J Schultz Journal: Cardiovasc Res Date: 2017-11-01 Impact factor: 10.787